Redacted study protocol. KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma
dataset
posted on 2021-05-12, 09:03 authored by Josep Tabernero, Yung-Jue Bang, Eric Van Cutsem, Charles S Fuchs, Yelena Yuriy Janjigian, Pooja Bhagia, Kan Li, David Adelberg, Shu Kui Qin|
Redacted study protocol
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma |
